CCNG2P1

Across TCGA pan-cancer cohorts, CCNG2P1 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated CCNG2P1 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher CCNG2P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CCNG2P1 expression acts as an unfavorable survival marker, although some lineages such as PAAD and KIRP show a favorable association.

UVM, THCA, and PAAD are the cancer types where CCNG2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Tertile	All	0.358	0.761	.001	63	view →
THCA	DFS	Tertile	IV	0.311	0.823	<.001	57	view →
PAAD	DFS	Tertile	All	0.577	0.246	.006	30	view →
HNSC	DFS	Tertile	IV	0.234	0.592	.002	18	view →
DLBC	DFS	Tertile	III,IV	0.137	0.790	<.001	18	view →
THYM	DFS	Tertile	All	0.739	0.887	.022	15	view →
LGG	DFS	Tertile	All	0.603	0.782	.008	12	view →
STAD	DFS	Tertile	All	0.193	0.440	.016	12	view →
SKCM	DFS	Tertile	IV	0.111	0.694	.004	9	view →
BLCA	OS	Tertile	IV	0.183	0.585	.031	9	view →
KIRP	OS	Tertile	II,III,IV	0.935	0.680	.040	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

CCNG2P1–UVM (DFS)

Open the UVM breakdown →